Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin and Anastrozole in Male Metastatic Breast Cancer
NCT00217659Phase 2Withdrawn
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2005
- Primary completion
- Jan 2007
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole, goserelin in breast cancer, sponsored by SWOG Cancer Research Network. Planned start Sep 2005; status: withdrawn.
02
Drugs
anastrozolegoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00217659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217659.